Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Dermatologic 2

Conditions

Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 2

Interventions

mogamulizumab 7Specimen Handling 5Immunoglobulin G 5Disulfides 5Cyclophosphamide 5Biopsy 5pembrolizumab 4fludarabine 4Magnetic Resonance Spectroscopy 4Brentuximab Vedotin 4hypericin 3fludarabine phosphate 3cemiplimab 3Radiotherapy 3Nivolumab 3sodium-iodide symporter 2X-Rays 2Whole-Body Irradiation 2Tacrolimus 2Phototherapy 2Photons 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Busulfan 2talimogene laherparepvec 1ruxolitinib 1romidepsin 1magrolimab 1duvelisib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Mycosis Fungoides × hypericin × 1 year × Clear all
NCT06470451 2026-04-03

FLASH2

Soligenix

Phase 3 Recruiting
80 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT05872854 2026-02-09

RW-HPN-MF-01

Abramson Cancer Center at Penn Medicine

Phase 2 Completed
10 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT06149247 2025-08-20

HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL

Soligenix

Phase 2 Completed
10 enrolled 7 charts
Lymphoid

Mycosis Fungoides

Data powered by HemOnc (CC BY 4.0) Colophon âš¡